The London Bioscience Innovation Centre
2 Royal College Street
10 articles with Synthace Ltd
5/21/2021Biopharma and life sciences companies strengthen their leadership teams and board with these Movers & Shakers.
Veteran Technology Executive Joins Synthace to Accelerate its Mission to Revolutionize the Life Science Research Market
Synthace Ltd, the cloud-based software platform for automating biological R&D, announced the appointment of Guy Levy-Yurista as Chief Executive Officer and Board Member to guide Synthace through its next stage of growth.
Synthace More Than Doubles Its Annual Recurring Revenue; Expands Customer Footprint With the Top Pharma Companies In 2020
Strong financial performance and the achievement of other key milestones demonstrate the growing strength of Synthace’s offering within the biopharma and biotech industries.
Synthace Ltd, the company behind Antha, the cloud-based software platform for automating and improving the success rate of biological processes, announced the appointment of Nick Jurascheck as VP of Engineering.
Two European leaders in biopharma and integrative software are working together to advance drug discovery
Leading Computer-Aided Biology company develops an innovative new approach to automating the ELISA
Synthace and Tecan Announce Collaboration to Accelerate Purification Optimization in Process Development through Augmented Lab Automation
Synthace Ltd, the company behind Antha, the cloud-based software platform for automating and improving the success rate of biological processes, and the Tecan Group announce a partnership to deepen the integration between Synthace’s Antha software and Tecan’s Te-Chrom™ automated chromatography system to unlock the full potential of miniaturized protein purification.
Gilson and Synthace Announce Collaboration Aiming to Make Biological Research More Efficient and Reproducible at Analytica 2018
Synthace’s Antha Software Makes Gilson’s PIPETMAX More Flexible and Easier to Use